Donate to PCRI: pcri.org/donate/
For more information, visit pcri.org
0:22 What is the difference between a "genetic" and a "genomic" test?
1:12 How important is genetic or genomic testing to the average prostate cancer patient?
3:31 Do 5% of people have a BRCA mutation?
3:42 Should all prostate cancer patients test to see if they have a BRCA mutation?
5:09 What are "somatic" and "germline" testing?
5:56 What tests are most often used to check for BRCA mutation, and when?
7:40 Why is that patients on active surveillance are so unlikely to die from prostate cancer?
8:21 In what other contexts are genetic tests useful for prostate cancer patients?
10:14 What are the usual next steps after a patient gets their genetic test results?
10:45 How can patients best understand the results of their genetic test?
12:19 Are genetic tests usually covered by insurance and Medicare?
12:34 Is it a matter of all men should be tested?
14:01 How impactful are genetic tests on the average patient's treatment plan?
15:08 Alex's conclusions
16:39 If you need more information
Don't know your stage? Take the quiz: visit prostatecancerstaging.org
To learn more about prostate cancer, visit pcri.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: pcri.org/join
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
- Genetic Testing For Prostate Cancer | BRCA | #MarkScholzMD #AlexScholz #PCRI ( Download)
- BRCA & PARP Inhibitors: Targeted Chemotherapy | #MarkScholzMD #AlexScholz @PCRI ( Download)
- Managing Terminal Prostate Cancer | #MarkScholzMD #AlexScholz #PCRI ( Download)
- BRCA Testing and Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MD ( Download)
- Treating Advanced #ProstateCancer with a High PSA | #MarkScholzMD #AlexScholz #PCRI ( Download)
- BRCA, MSI, and Useful Genetic Tests in Prostate Cancer | Answering YouTube Comments #45 | PCRI ( Download)
- New FDA Approved PARP Inhibitor: Talzenna (Talazoparib) & Xtandi | #markscholzmd #AlexScholz #pcri ( Download)
- Genetic Testing for Prostate Cancer ( Download)
- PI-RADS, Active Surveillance Protocols for 3+3=6 & 3+4=7, & Genomic/Genetics Tests | Mark Scholz, MD ( Download)
- Advanced #ProstateCancer Treatments + Extended Q+A | #MarkScholzMD & #MarkMoyadMD #PCRI ( Download)
- Diagnosis Without Biopsy, Lymph Nodes, 2nd Gen Hormone Treatments | Answering YouTube Comments #4 ( Download)
- Genetic Testing in Advanced Prostate Cancer ( Download)
- Treatments for Advanced Prostate Cancer in 2022 | Evan Yu, MD | PCRI ( Download)
- What is Nubeqa for Prostate Cancer and How Does it Work | Ask a Prostate Expert, Mark Scholz, MD ( Download)
- Advanced #ProstateCancer Treatments | Eugene Kwon, MD | DIY Combat Manual | Part 5 #PCRI ( Download)
